Solo Jobs In Germany - 578 Job Positions Available

Deine Spielwiese shyftplan ist die All-in-One-Lösung zur Schichtplanung für Industriekunden. Unsere Software vereinfacht komplexe Personaleinsatzplanung, senkt Kosten und bindet Mitarbeitende aktiv mit ein. Wir arbeiten mit namhaften Industrie-Playern wie B. Braun, Omterra und Haribo und haben

ABOUT US P3 is a long-term investor, manager and developer of European warehouse properties with more than 10.2 million m² of assets under management and land bank of 1.7 million m² of future gross lettable area

ESPECIALISTA JR INTELIGENCIA ARTIF E INN Ingeniero de IA Generativa JR (CDMX ó Monterrey) En Banorte buscamos talento único, fuerte y extraordinario, que impulse la transformación e innovación del país, convirtiéndonos en un gran aliado para

Coverflex Coverflex started with a simple observation: work changed, but compensation didn’t. A few founders looked at how people were being paid across Europe — rigid salary structures, fragmented benefits, systems that were complex for HR

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)

Bei Superchat gestalten wir neu, wie Unternehmen mit ihren Kund:innen kommunizieren. KI wird dabei immer mehr zum Motor dieser Kommunikation. Integrationen sind das, was diesem Motor echte Power gibt: die Daten, Tools und Systeme, die aus

Bei Superchat gestalten wir neu, wie Unternehmen mit ihren Kund:innen kommunizieren. KI wird dabei immer mehr zum Motor dieser Kommunikation. Integrationen sind das, was diesem Motor echte Power gibt: die Daten, Tools und Systeme, die aus

This isn’t your regular job. Almedia is a place where those who want to push harder can accelerate their careers faster than anywhere else. We’re aiming to become Germany’s second bootstrapped unicorn. Almedia is already Europe’s

Bei Superchat gestalten wir neu, wie Unternehmen mit ihren Kund:innen kommunizieren. KI wird dabei immer mehr zum Motor dieser Kommunikation. Integrationen sind das, was diesem Motor echte Power gibt: die Daten, Tools und Systeme, die aus

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)

Hi! We are AMBOSS and we are looking for a Backend Engineer to join our Educator Experience team, and shape the future of medical education with us! About AMBOSS AMBOSS is a dynamic learning and clinical

Detalles del empleo: Pathmonk es una empresa que prioriza a los empleados, lo que significa que la felicidad y el bienestar de ellos es nuestra máxima prioridad. Nuestro equipo y estilo de trabajo se basa en

Hi! We are AMBOSS and we are looking for a Senior Frontend Engineer to join our Educator Experience team, and shape the future of medical education with us! About AMBOSS AMBOSS is a dynamic learning and

Job Description SummarySupport the deployment of robotic systems in manufacturing facilities in Europ, with a specific focus on digital integration aspects Job Description ​The role consists mainly to : Identify and support the implementation of robotization

Our Mission At Circus, headquartered in Munich with an office in Hamburg, we are pioneering global developments in on-demand autonomous food production. Everything from creation to production and operation – enabled by seamlessly integrated cutting-edge robotics

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)